Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.
Gerasimos S FilippatosJaved ButlerDimitrios FarmakisFaiez ZannadAnne Pernille OfstadJoao Pedro FerreiraJennifer B GreenJulio RosenstockSven SchnaidtMartina BrueckmannStuart J PocockMilton PackerStefan D Ankernull nullPublished in: Circulation (2022)
gov; Unique identifier: NCT03057951.
Keyphrases
- ejection fraction
- heart failure
- left ventricular
- aortic stenosis
- cardiac resynchronization therapy
- type diabetes
- cardiovascular disease
- glycemic control
- hypertrophic cardiomyopathy
- acute myocardial infarction
- mitral valve
- left atrial
- acute heart failure
- atrial fibrillation
- transcatheter aortic valve replacement
- aortic valve
- coronary artery disease
- adipose tissue
- percutaneous coronary intervention